about
Advances in drug delivery system for platinum agents based combination therapyAtlas of Cancer Signalling Network: a systems biology resource for integrative analysis of cancer data with Google MapsSynthetic biology for therapeutic applications.Multiscale analysis of the murine intestine for modeling human diseases.Decoupling of the PI3K Pathway via Mutation Necessitates Combinatorial Treatment in HER2+ Breast CancerRapid optimization of drug combinations for the optimal angiostatic treatment of cancerSHP2, SOCS3 and PIAS3 Expression Patterns in Medulloblastomas: Relevance to STAT3 Activation and Resveratrol-Suppressed STAT3 Signaling.Dietary ω -3 polyunsaturated fatty acid DHA: a potential adjuvant in the treatment of cancer.Global connectivity of hub residues in Oncoprotein structures encodes genetic factors dictating personalized drug response to targeted Cancer therapy.Chemoresistance to gemcitabine in hepatoma cells induces epithelial-mesenchymal transition and involves activation of PDGF-D pathway.Synergistic effects of combining proteasome inhibitors with chemotherapeutic drugs in lung cancer cells.On-demand dissolution of modular, synthetic extracellular matrix reveals local epithelial-stromal communication networks.Intrinsic and induced drug resistance mechanisms: in silico investigations at the cellular and tissue scales.A 35-gene signature discriminates between rapidly- and slowly-progressing glioblastoma multiforme and predicts survival in known subtypes of the cancer.
P2860
Q26771390-B8360153-966B-45E5-9571-6DBAF457C26FQ30659572-94F35432-1965-4747-AEC9-7269EA7BB43AQ35057524-8EF20C3E-846D-442C-8B46-929CBFF9116BQ35651919-7ABD9280-E1AE-4388-A1D6-B3E9A16D7B77Q35693389-6CD23166-3E5A-4FCA-8466-79CDCFFCDDC7Q35757208-9B54C095-6454-4E32-80D8-93CBA9CF8CF3Q37628299-9FCA56D2-4166-482B-8AC0-0A0AE03BB924Q42146247-EFD8A45E-792E-4F9A-A9F1-BDCCB47BA29CQ42233673-77C234BA-295F-442D-8861-43894BDC5C1EQ42770276-8E7A9D9B-D53D-4841-8FE1-BF061AB72AF6Q44006947-37E5762C-FD41-4FEA-BFA6-35E38CF760CAQ50933362-5580E568-D605-47FB-888F-895121062772Q51833938-F1F02797-4F77-413B-9EAC-AF6ACAFBE41AQ53698804-006DC03C-0C57-4167-BF7B-B52F45BE6656
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Understanding resistance to combination chemotherapy.
@en
type
label
Understanding resistance to combination chemotherapy.
@en
prefLabel
Understanding resistance to combination chemotherapy.
@en
P2860
P1476
Understanding resistance to combination chemotherapy.
@en
P2093
Justin R Pritchard
Michael T Hemann
P2860
P304
P356
10.1016/J.DRUP.2012.10.003
P577
2012-10-01T00:00:00Z